Sisram Medical Ltd, together with its subsidiaries, researches, designs, develops, manufactures, sells, and markets medical aesthetics and dental equipment, home-use devices, injectables, and cosmeceutical products across Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America. Its product portfolio addresses clinical aesthetic indications such as hair removal, skin rejuvenation, acne and acne scars, trans-epidermal delivery, face and body contouring, cellulite treatment, stretch marks, vascular and pigmented lesions, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue remodeling, injectables, personal care, aesthetic dentistry, hydradermabrasion, blepharoplasty (nonsurgical eyelid lift), liposuction, feminine health, and sexual rehabilitation. The company also conducts pharmaceutical research and development. Its products are offered under the Alma, LMNT, Copulla, Profhilo, and Aliaxin brands. Founded in 1999, Sisram Medical Ltd is headquartered in Caesarea, Israel.